Bio Path Holdings Inc reports results for the quarter ended in December - Earnings Summary

Bio Path Holdings

11/03/2022 14:31

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly
adjusted
loss of 59 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 32 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bio Path Holdings Inc shares had fallen by 8.0% this
quarter.
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $12.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 02:31 p.m.  ​All
figures in US dollars unless otherwise stated